TY - JOUR
T1 - Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome)
T2 - An update
AU - Veggiotti, Pierangelo
AU - Pera, Maria Carmela
AU - Teutonico, Federica
AU - Brazzo, Daniela
AU - Balottin, Umberto
AU - Tassinari, Carlo Alberto
PY - 2012/3
Y1 - 2012/3
N2 - Electrical status epilepticus in sleep (ESES)/continuous spikes andwaves during slow sleep (CSWS) is an age-related, self-limiting disorder characterised by epilepsy with different seizure types, global or selective neuropsychological regression, motor impairment, and a typical EEG pattern of continuous epileptiform activity for more than 85% of non-rapid eye movement (NREM) sleep. Although the first description of ESES/CSWS dates back to 1971, an agreement about the optimal treatment for this condition is still lacking. ESES/CSWS is rare (incidence is 0.2-0.5% of all childhood epilepsies) and no controlled clinical trials have been conducted to establish the efficacy of different antiepileptic drugs; only uncontrolled studies and case reports are reported in the literature. Treatment options for ESES/CSWS include some antiepileptic drugs (valproic acid, ethosuximide, levetiracetam, and benzodiazepines), steroids, immunoglobulins, the ketogenic diet, and surgery (multiple subpial transections). In this study, the comparative value of each of these treatments is reviewed and a personal therapeutic approach is proposed.
AB - Electrical status epilepticus in sleep (ESES)/continuous spikes andwaves during slow sleep (CSWS) is an age-related, self-limiting disorder characterised by epilepsy with different seizure types, global or selective neuropsychological regression, motor impairment, and a typical EEG pattern of continuous epileptiform activity for more than 85% of non-rapid eye movement (NREM) sleep. Although the first description of ESES/CSWS dates back to 1971, an agreement about the optimal treatment for this condition is still lacking. ESES/CSWS is rare (incidence is 0.2-0.5% of all childhood epilepsies) and no controlled clinical trials have been conducted to establish the efficacy of different antiepileptic drugs; only uncontrolled studies and case reports are reported in the literature. Treatment options for ESES/CSWS include some antiepileptic drugs (valproic acid, ethosuximide, levetiracetam, and benzodiazepines), steroids, immunoglobulins, the ketogenic diet, and surgery (multiple subpial transections). In this study, the comparative value of each of these treatments is reviewed and a personal therapeutic approach is proposed.
KW - AEDs
KW - ESES
KW - Steroids
UR - http://www.scopus.com/inward/record.url?scp=84859468971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859468971&partnerID=8YFLogxK
U2 - 10.1684/epd.2012.0482
DO - 10.1684/epd.2012.0482
M3 - Article
C2 - 22426353
AN - SCOPUS:84859468971
SN - 1294-9361
VL - 14
SP - 1
EP - 11
JO - Epileptic Disorders
JF - Epileptic Disorders
IS - 1
ER -